From memory... I believe one of the recent broker reports conceded that that the stock was massively undevalued to peers (ie Peers in Botswana with less jorc) and the "likely" catalyst for a rerate process was the announcement of a +ive scoping study. I' reckon give it a few days for the market to swallow the news do their peer comparisons ..perhaps for the Company to give a bit more detail and then we will be away....
All is IMHO DYOR to confirm
NMR Price at posting:
3.6¢ Sentiment: Hold Disclosure: Held